LP002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LP002, covering 2020-10-23 to 2021-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]